Literature DB >> 9607196

Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties.

G B Schwochau1, K A Nath, M E Rosenberg.   

Abstract

Perturbations of cell interactions, an early event in acute renal injury, have important pathophysiologic consequences. We hypothesized that promotion of cell interactions protects cells from injury. To test this hypothesis, a single cell suspension of LLC-PK1 cells (porcine proximal tubular cell line) treated with albumin (control) was compared to cells aggregated with fibrinogen or purified human clusterin (aggregation graded 0 to 4). Following aggregation, the cells were injured with 1.5 mM hydrogen peroxide (H2O2) for three hours. Cell aggregation induced by clusterin but not fibrinogen protected against oxidant injury by H2O2. Complete abrogation of cytotoxicity occurred at a clusterin concentration of 2.5 micrograms/ml, which resulted in an aggregation score of 1. In the absence of aggregation, clusterin at concentrations of 20 and 50 micrograms/ml, but not lower doses, partially protected against injury induced by H2O2. Cell aggregation induced by both clusterin and fibrinogen partially protected against endogenously generated oxidant stress induced by incubating LLC-PK1 cells with aminotriazole and 1-chloro-2,4-dinitrobenzene (CDNB). In conclusion, clusterin protects against models of oxidant stress in vitro, whether generated by exogenously administered hydrogen peroxide, or from endogenously produced peroxide, and such protective effects can accrue from aggregative and nonaggregative properties of clusterin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607196     DOI: 10.1046/j.1523-1755.1998.00902.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  25 in total

Review 1.  Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisense oligonucleotides to enhance androgen- and chemo-sensitivity in prostate cancer.

Authors:  Martin E Gleave; Toby Zellweger; Kim Chi; Hideaki Miyake; Satoshi Kiyama; Laura July; Simon Leung
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850

Review 2.  Androgens and prostate cancer.

Authors:  Alan I So; Antonio Hurtado-Coll; Martin E Gleave
Journal:  World J Urol       Date:  2003-10-29       Impact factor: 4.226

3.  Increased clusterin expression in Fuchs' endothelial dystrophy.

Authors:  Ula V Jurkunas; Maya S Bitar; Ian Rawe; Deshea L Harris; Kathryn Colby; Nancy C Joyce
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-31       Impact factor: 4.799

4.  Clusterin attenuates the development of renal fibrosis.

Authors:  Gwon-Soo Jung; Mi-Kyung Kim; Yun-A Jung; Hye-Soon Kim; In-Sun Park; Bon-Hong Min; Ki-Up Lee; Jung-Guk Kim; Keun-Gyu Park; In-Kyu Lee
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

Review 5.  Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer.

Authors:  Martin Gleave; Hideaki Miyake
Journal:  World J Urol       Date:  2005-01-26       Impact factor: 4.226

Review 6.  Mechanisms of the development of androgen independence in prostate cancer.

Authors:  Alan So; Martin Gleave; Antonio Hurtado-Col; Colleen Nelson
Journal:  World J Urol       Date:  2005-01-27       Impact factor: 4.226

7.  The role of clusterin in retinal development and free radical damage.

Authors:  Jeong Hun Kim; Jin Hyoung Kim; Young Suk Yu; Bon-Hong Min; Kyu-Won Kim
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

8.  Vanadium-induced apoptosis of HaCaT cells is mediated by c-fos and involves nuclear accumulation of clusterin.

Authors:  Soultana Markopoulou; Evangelos Kontargiris; Christina Batsi; Theodore Tzavaras; Ioannis Trougakos; David A Boothman; Efstathios S Gonos; Evangelos Kolettas
Journal:  FEBS J       Date:  2009-06-15       Impact factor: 5.542

9.  Protective effect of clusterin on oxidative stress-induced cell death of human corneal endothelial cells.

Authors:  Young Joo Shin; Jeong Hun Kim; Jong Mo Seo; Sang Mok Lee; Joon Young Hyon; Young Suk Yu; Won Ryang Wee
Journal:  Mol Vis       Date:  2009-12-16       Impact factor: 2.367

10.  Different altered stage correlative expression of high abundance acute-phase proteins in sera of patients with epithelial ovarian carcinoma.

Authors:  Yeng Chen; Boon-Kiong Lim; Onn H Hashim
Journal:  J Hematol Oncol       Date:  2009-08-27       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.